An Evidence-Based Systematic Review of Passion Flower (Passiflora Incarnata L.) by the Natural Standard Research Collaboration

REFERENCES

• Akhondzadeh S, Kashani L, Mobaseri M, Hosseini S H, Nikzad S, Khani M. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J Clin Pharm Ther 2001; 26(5)369–73, View abstract
   Google Scholar
• Akhondzadeh S, Naghavi H R, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther 2001; 26(5)363–67, View abstract
   Web of Science ®Google Scholar
• Aoyagi N, Kimura R, Murata T. Studies on passiflora incarnata dry extract. I. Isolation of maltol and pharmacological action of maltol and ethyl maltol. Chem Pharm Bull (Tokyo) 1974; 22(5)1008–13, View abstract,
   Google Scholar
• Birner J, Nicolls J M. Passicol, an antibacterial and antifungal agent produced by Passiflora plant species: preparation and physicochemical characteristics. Antimicrob Agents Chemother 1973; 3(1)105–109, View abstract
   Google Scholar
• Bourin M, Bougerol T, Guitton B, Broutin E. A combination of plant extracts in the treatment of outpatients with adjustment disorder with anxious mood: controlled study versus placebo. Fundam Clin Pharmacol 1997; 11(2)127–32, View abstract
   PubMed Web of Science ®Google Scholar
• Brown E, Hurd N S, McCall S, Ceremuga T E. Evaluation of the anxiolytic effects of chrysin, a Passiflora incarnata extract, in the laboratory rat. AANA J. 2007; 75(5)333–37, View abstract
   Google Scholar
• Capasso A, Pinto A. Experimental investigations of the synergistic-sedative effect of passiflora and kava. Acta Therapeutica 1995; 21: 127–40
   Google Scholar
• Capasso A, Sorrentino L. Pharmacological studies on the sedative and hypnotic effect of Kava kava and Passiflora extracts combination. Phytomedicine 2005; 12(1–2)39–45, View abstract
   Google Scholar
• Congura M. Isolement et identification de deux glycosyl-luteolines mono-C-substituees et de la diglucosyl-6–8-luteoline di-C-substituee dans les tiges feuillees de Passiflora incarnata L. Helvitica Chimica Acta 1986; 69: 251–53
   Google Scholar
• Dhawan K. Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn—a brief perspective. Addict Biol. 2003; 8(4)379–86, View abstract
   Google Scholar
• Dhawan K, Dhawan S, Chhabra S. Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiety of Passiflora incarnata Linneaus: a non-habit forming anxiolytic. J Pharm Pharm Sci 2003; 6(2)215–22, View abstract
   Google Scholar
• Dhawan K, Kumar S, Sharma A. Antiasthmatic activity of the methanol extract of leaves of Passiflora incarnata. Phytother Res. 2003a; 17(7)821–22, View abstract
   Google Scholar
• Dhawan K, Kumar S, Sharma A. Aphrodisiac activity of methanol extract of leaves of Passiflora incarnata Linn in mice. Phytother Res. 2003b; 17(4)401–403, View abstract
   Google Scholar
• Dhawan K, Kumar S, Sharma A. Comparative biological activity study on Passiflora incarnata and P. edulis. Fitoterapia 2001; 72(6)698–702, View abstract
   PubMedGoogle Scholar
• Dhawan K, Kumar S, Sharma A. Suppression of alcohol-cessation-oriented hyper-anxiety by the benzoflavone moiety of Passiflora incarnata Linneaus in mice. J Ethnopharmacol 2002; 81(2)239–44, View abstract
   Google Scholar
• Dhawan K, Sharma A. Antitussive activity of the methanol extract of Passiflora incarnata leaves. Fitoterapia 2002; 73(5)397–99, View abstract
   Google Scholar
• Farnsworth N R, Bingel A S, Cordell G A, Crane F A, Fong H H. Potential value of plants as sources of new antifertility agents I. J Pharm Sci. 1975; 64(4)535–98, View abstract
   PubMed Web of Science ®Google Scholar
• Fisher A A, Purcell P, Le Couteur D G. Toxicity of Passiflora incarnata L. J Toxicol Clin Toxicol 2000; 38(1)63–66, View abstract
   PubMed Web of Science ®Google Scholar
• Gerhard U, Hobi V, Kocher R, Konig C. Acute sedative effect of a herbal relaxation tablet as compared to that of bromazepam. Schweiz Rundsch Med Prax 1991; 80(52)1481–86, View abstract
   Google Scholar
• Giavina-Bianchi P F, Jr, Castro F F, Machado M L, Duarte A J. Occupational respiratory allergic disease induced by Passiflora alata and Rhamnus purshiana. Ann Allergy Asthma Immunol 1997; 79(5)449–54, View abstract,
   Google Scholar
• Hidaka M, Fujita K, Ogikubo T, Yamasaki K, Iwakiri T, Okumura M, Kodama H, Arimori K. Potent inhibition by star fruit of human cytochrome P450 3A (CYP3A) activity. Drug Metab Dispos 2004; 32(6)581–83, View abstract
   PubMedGoogle Scholar
• Ichimura T, Yamanaka A, Ichiba T, Toyokawa T, Kamada Y, Tamamura T, Maruyama S. Antihypertensive effect of an extract of Passiflora edulis rind in spontaneously hypertensive rats. Biosci Biotechnol Biochem 2006; 70(3)718–21, View abstract
   PubMed Web of Science ®Google Scholar
• Israel D, Youngkin E Q. Herbal therapies for perimenopausal and menopausal complaints. Pharmacotherapy 1997; 17(5)970–84, View abstract
   PubMed Web of Science ®Google Scholar
• Jadad A R, Moore R A, Carroll D, Jenkinson C, Reynolds D J, Gavaghan D J, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996; 17(1)1–12
   PubMedGoogle Scholar
• Karaki H, Kishimoto T, Ozaki H, Sakata K, Umeno H, Urakawa N. Inhibition of calcium channels by harmaline and other harmala alkaloids in vascular and intestinal smooth muscles. Br J Pharmacol 1986; 89(2)367–75, View abstract
   PubMed Web of Science ®Google Scholar
• Mahady G B, Pendland S L, Stoia A, Hamill F A, Fabricant D, Dietz B M, Chadwick L R. In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res. 2005; 19(11)988–91, View abstract
   PubMed Web of Science ®Google Scholar
• Medina J H, Paladini A C, Wolfman C, Levi de Stein Calvo D, Diaz L E, Pena C. Chrysin (5,7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors, with anticonvulsant properties. Biochem Pharmacol. 1990; 40(10)2227–31, View abstract
   PubMed Web of Science ®Google Scholar
• Menghini A, Mancini L A. TLC determination of flavonoid accumulation in clonal populations of Passiflora incarnata L. Pharmacol Res Commun. 1988; 20(Suppl. 5)113, –16. View abstract
   Google Scholar
• Mourvaki E, Gizzi S, Rossi R, Rufini S. Passionflower fruit-a “new” source of lycopene?. J Med Food. 2005; 8(1)104–106, View abstract
   PubMed Web of Science ®Google Scholar
• Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med. 2007; 7: 26, View abstract
   PubMedGoogle Scholar
• Passalacqua N G, Guarrera P M, De Fine G. Contribution to the knowledge of the folk plant medicine in Calabria region (Southern Italy). Fitoterapia 2007; 78(1)52–68, View abstract
   PubMed Web of Science ®Google Scholar
• Perry N B, Albertson G D, Blunt J W, Cole A L, Munro M H, Walker J R. 4-Hydroxy-2-cyclopentenone: an anti-pseudomonas and cytotoxic component from Passiflora tetrandra. Planta Med 1991; 57(2)129–31, View abstract
   Google Scholar
• Quercia V, Turchetto L, Pierini V, et al. Identification and determination of vitexin and isovitexin in Passiflora incarnata extracts. J Chromatogr 1978; 161: 396–402
   Web of Science ®Google Scholar
• Ramirez-Duron R, Ceniceros-Almaguer L, Salazar-Aranda R, Salazar-Cavazos Mde L, de Torres Waksman. Evaluation of thin-layer chromatography methods for quality control of commercial products containing Aesculus hippocastanum, Turnera diffusa, Matricaria recutita, Passiflora incarnata, and Tilia occidentalis. J AOAC Int. 2007; 90(4)920–24, View abstract,
   Google Scholar
• Rickels K, Hesbacher P T. Over-the-counter daytime sedatives. A controlled study. JAMA 1973; 223(1)29–33, View abstract
   PubMed Web of Science ®Google Scholar
• Rommelspacher H, May T, Salewski B. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats. Eur J Pharmacol 1994; 252(1)51–59, View abstract
   Google Scholar
• Saenz J A, Nassar M. Toxic effect of the fruit of Passiflora adenopoda D.C. on humans: phytochemical determination. Rev Biol Trop. 1972; 20(1)137–40, View abstract
   Google Scholar
• Salgueiro J B, Ardenghi P, Dias M, Ferreira M B, Izquierdo I, Medina J H. Anxiolytic natural and synthetic flavonoid ligands of the central benzodiazepine receptor have no effect on memory tasks in rats. Pharmacol Biochem Behav. 1997; 58(4)887–91, View abstract
   Google Scholar
• Smith G W, Chalmers T M, Nuki G. Vasculitis associated with herbal preparation containing Passiflora extract. Br J Rheumatol. 1993; 32(1)87–88, View abstract
   Google Scholar
• Solbakken A M, Rorbakken G, Gundersen T. Nature medicine as intoxicant. Tidsskr Nor Laegeforen 1997; 117(8)1140–41, View abstract
   Google Scholar
• Soulimani R, Younos C, Jarmouni S, Bousta D, Misslin R, Mortier F. Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse. J Ethnopharmacol 1997; 57(1)11–20, View abstract
   PubMed Web of Science ®Google Scholar
• Spencer K C, Seigler D S. Cyanogenesis of Passiflora edulis. J Agric Food Chem 1983; 31(4)794–96, View abstract
   Google Scholar
• Spencer K C, Seigler D S. Gynocardin from Passiflora. Planta Med. 1984; 50(4)356–57, Speroni E, Minghetti A. Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med. 1988;54(6):488–91. View abstract
   Google Scholar
• Von Eiff M, Brunner H, Haegeli A, et al. Hawthorn/passion flower extract and improvement in physical exercise capacity of patients with dyspnoea Class II of the NYHA functional classifications. Acta Therapeutica 1994; 20: 47–66
   Google Scholar
• Wolfman C, Viola H, Paladini A, Dajas F, Medina J H. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav. 1994; 47(1)1–4, View abstract.
   PubMed Web of Science ®Google Scholar
• Yaniv R, Segal E, Trau H, Auslander S, Perel A. Natural premedication for mast cell proliferative disorders. J Ethnopharmacol 1995; 46(1)71–72, View abstract
   Google Scholar